Search results
Results from the WOW.Com Content Network
However, a single small study of trans men after oophorectomy demonstrated that androgens alone may be insufficient to slow bone loss. [47] It is likely the case that pre-oophorectomy, residual estrogen production is protective. However, after oophorectomy, some trans men may have insufficient estrogen to slow bone loss.
Hysterectomy is a surgical procedure performed to remove the uterus. A total hysterectomy involves removal of the uterus and cervix, and a sub-partial hysterectomy involves removal of only the uterus. Bilateral salpingo-oophorectomy (BSO) is the removal of both ovaries and fallopian tubes.
This is thought to be caused by the changes in blood flow to the ovaries after a hysterectomy, during which many small blood vessels are cut and sealed. But the right hormone replacement therapy ...
Why Hair Loss after Hysterectomy Surgery Occurs. There are a few reasons why hair loss might occur after a hysterectomy. Below, we unpack the relationship between hysterectomy and hair loss. 1. Stress
Most bilateral oophorectomies (63%) are performed without any medical indication, and most (87%) are performed together with a hysterectomy. [9] Conversely, unilateral oophorectomy is commonly performed for a medical indication (73%; cyst, endometriosis, benign tumor, inflammation, etc.) and less commonly in conjunction with hysterectomy (61%).
Ovarian remnant (ORS) may first be considered in women who have undergone oophorectomy and have suggestive symptoms, the presence of a mass, or evidence of persistent ovarian function (by symptoms or laboratory testing). A history of oophorectomy is required, by definition, to make the diagnosis.
Olivia Munn recently shared that she had a hysterectomy, a surgery that removes your uterus, along with a salpingo-oophorectomy, or the surgical removal of both ovaries and fallopian tubes ...
Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity.